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Stanford, CaliforniaABSTRACT The aggregation of amyloid beta (Ab) peptides plays an important role in the development of Alzheimer’s disease.
Despite extensive effort, it has been difficult to characterize the secondary and tertiary structure of the Abmonomer, the starting
point for aggregation, due to its hydrophobicity and high aggregation propensity. Here, we employ extensive molecular dynamics
simulations with atomistic protein and water models to determine structural ensembles for Ab42, Ab40, and Ab42-E22K (the Italian
mutant) monomers in solution. Sampling of a total of >700 microseconds in all-atom detail with explicit solvent enables us to
observe the effects of peptide length and a pathogenic mutation on the disordered Ab monomer structural ensemble. Ab42
and Ab40 have crudely similar characteristics but reducing the peptide length from 42 to 40 residues reduces b-hairpin formation
near the C-terminus. The pathogenic Italian E22K mutation induces helix formation in the region of residues 20–24. This struc-
tural alteration may increase helix-helix interactions between monomers, resulting in altered mechanism and kinetics of Ab
oligomerization.INTRODUCTIONAlzheimer’s disease (AD) is a progressive degenerative
brain disorder and the most common cause for dementia
(1). There is currently no cure for AD. Senile plaques
composed of fibers formed primarily from amyloid beta
(Ab) peptides in the brains of AD patients are a pathological
hallmark of AD (2,3). The ~4-kDa Ab peptide in senile
plaques is a proteolytic product of the Ab precursor protein
(APP). Due to the ability of the protease g-secretase to
cleave APP at multiple sites (at the C-terminus of Ab),
Ab peptides are 39 to 43 amino acid residues in length,
but Ab40 and Ab42 are the predominant species in vivo
(4). In contrast, senile plaques in AD are composed pri-
marily of Ab42 and Ab43 (5). Ab42 and Ab43 are more
hydrophobic and aggregation-prone than the slightly shorter
and more polar (but very abundant) Ab40. A number of
mutations in APP have been related to familial AD (6,7).
The mutations usually occur at or near the b- and g-secre-
tase cleavage sites, resulting in more production of Ab
peptides or an increased ratio of Ab42/Ab40 (7). In addition
to the mutations at or near the secretase cleavage sites, there
are five pathogenic mutations in the region of A21, E22, and
D23 in the Ab sequence: the Flemish A21G mutation,
Arctic E22G mutation, Dutch E22Q mutation, Italian
E22K mutation, and Iowa D23N mutation. These muta-
tions modify the biochemistry of Ab peptides and lead to
AD, congophilic amyloid angiopathy, or hereditary cerebral
hemorrhage with amyloid (7). Thus, these genetic studies
support a central role for Ab in AD.Submitted August 18, 2011, and accepted for publicationDecember 1, 2011.
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0006-3495/12/01/0315/10 $2.00The structure of amyloid plaques is rather well resolved.
Amyloid plaques appear fibrillar under an electron micro-
scope (8). X-ray diffraction patterns suggest the formation
of cross-b-sheets in amyloid fibrils (9). Solid-state NMR
results confirm that amyloid fibrils composed of Ab42 are
cross-b-sheets, arranged in-register in a parallel fashion.
A three-dimensional structure has been proposed (10,11).
In contrast to the amyloid fibril, the three-dimensional struc-
ture of the Ab monomer, the starting point for aggregation,
remains elusive. The absence of high-resolution structural
data for the Ab monomer is particularly troublesome
because it now appears likely that the toxic species in AD
is not the fibril, but rather an early-stage toxic oligomer of
controversial structure and size (12–23). Determining the
possible structures of toxic oligomers, and developing
means to avoid their formation, would be greatly aided by
a detailed understanding of the conformational ensemble
adopted by the Ab monomer. The hydrophobicity and
high aggregation propensity of the Ab monomer thwart
structure determination under physiological conditions by
traditional methods, including x-ray crystallography and
solution-phase NMR spectroscopy. NMR structural deter-
mination of full-length Ab with either an organic cosolvent
(for example, Ab42 in 80% hexafluoroisopropanol (24)) or
detergent (25) to prevent aggregation is possible, but the
physiological relevance of these results is, at best, unclear.
The structures of some short, monomeric Ab fragments
with enhanced water solubility have also been studied by
NMR spectroscopy (26–31). For example, Ab21–30 mono-
mer adopts a bend structure spanning residues 24–28 (30)
and Ab10–35 monomer forms a collapsed coil structure in
water (28), but it is unclear how relevant these fragment
conformations are to the structural ensemble adopted bydoi: 10.1016/j.bpj.2011.12.002
316 Lin et al.full-length Ab peptides (which have different biophysical
properties such as solubility, fibril structure, and aggregation
kinetics (11,28,32–34)).
Although it is difficult to determine a high-resolution
structure for full-length Ab in aqueous solution, some infor-
mation on its structure has been inferred from NMR mea-
surements (35,36). For example, the nuclear Overhauser
effect, amide-NH temperature coefficients and chemical
shift indices of 1Ha,
13Ca, and
13Cb suggest that both Ab42
and Ab40 adopt predominantly random chain structures
(35), although a partially folded structure of Ab40 has
been reported recently from 2D NMR data (37). The Ha
chemical shift indices suggest some tendency of resi-
dues 31–36 and 39–41 to populate b-strand conformations
for Ab42 and the absence of b-strand structure for the
C-terminal residues of Ab40 (35). Nonetheless, for confor-
mationally flexible biomolecules it is not straightforward
to interpret spectroscopic quantities to obtain representative
structures (38–40). In fact, it has been shown that secondary
structure assignment using NMR chemical shifts for intrin-
sically disordered peptides such as Ab may be generally
problematic (41). Another NMR study reported that Ab42
and Ab40 share similar relaxation rates and nuclear Over-
hauser effect values except at the C-terminus, indicating
Ab42 and Ab40 monomers have similar global motions
(36). The differences in spectral density function and order
parameters suggest that the Ab42 C-terminus is more rigid
than the Ab40 C-terminus (36).
Molecular dynamics (MD) simulations have been exten-
sively used to provide atomistic-level information on pro-
tein structure and dynamics ever since the first protein
MD simulation in 1977 (42), and have been applied to study
Ab peptides quite extensively. Below we briefly summarize
simulation approaches to understand the structure of Ab
monomers.
To enable sufficient sampling of Ab monomer configura-
tions, implicit solvent models are often used, sometimes
along with coarse-grained models for proteins (43,44). For
instance, discrete MD combined with a four-bead protein
model and implicit solvent has been used to study the effects
of the Arctic E22G mutation on full-length Ab. The authors
proposed that the mutation increased the average b-strand
propensity and disrupted contacts in the A21–A30 region
(44). Simulations of Ab peptides using fully atomistic
protein models and implicit solvent have also been reported
(45–49). Ab42 appeared disordered but showed some
sequence-dependent propensity to form regular secondary
structure (45,48,49). Compared to Ab40, the two additional
hydrophobic residues at the C-terminus increased the
b-structure in Ab42 (48,49).
Using explicit solvent models (rather than implicit
solvent models) to better describe the peptide-water interac-
tions is likely to be beneficial in MD simulations of Ab
peptides, which are, at most, weakly structured and have
very high solvent exposure. However, the use of explicitBiophysical Journal 102(2) 315–324solvent models demands great computing power to obtain
the amount of sampling that can be reached by implicit-
solvent simulations. MD simulations implementing explicit
solvent models have been performed on a number of Ab
fragments, whose sizes are usually of 10–20 residues,
and provided some potential insights into Ab structure
(29,31,50–67). For instance, from simulations of the 10
residue long Ab21–30, a bend structure between residues
24–28 was observed, consistent with the NMR study of
the fragment (30). This bend motif was found to be retained
in the E22 mutants of this Ab fragment (52).
MD simulations implementing explicit solvent models
have also been performed on full-length Ab (41,68–76).
For example, a number of researchers have generated short
trajectories (with a total simulation time<500 ns) beginning
with a highly helical Ab42 structure that was determined by
NMR studies of Ab42 in a water-organic solvent mixture
(68–72). These trajectories usually showed a loss of helical
structure after the helical Ab42 was placed in water in the
simulations. Several MD simulations using atomistic
models for peptide and explicit water models have been
performed to better characterize the structure of full-length
Ab in explicit water (41,73–76). Sgourakis et al. (73) per-
formed replica exchange MD to investigate structural differ-
ences between Ab42 and Ab40 monomer. By analyzing data
from 52 100-ns replicas, a number of representative confor-
mations were identified and the formation of a b-hairpin was
observed near the C-terminus of Ab42, but not of Ab40.
More recently, Sgourakis et al. performed replica exchange
MD of Ab42 using an improved simulation force field (77)
and obtained an aggregation simulation time of 11.7 ms,
during which the peptide sampled a highly diverse range
of conformations (74). These results provided useful infor-
mation on the solution structure of Ab monomer, but we
note that because Ab monomer may be intrinsically not
well structured and can clearly adopt numerous con-
figurations, it is crucial to characterize the structural en-
semble, rather than uncovering a handful of low free
energy states. Furthermore, there has been little attempt to
perform extensive MD simulations using explicit solvent
models on pathogenic (or other) mutants of Ab42, which
could provide essential information regarding how the struc-
tural ensemble of monomeric Ab can influence disease
progression (75).
Here, by using distributed computing and Markov state
model (MSM) analysis (78,79), we are able to sample on
an exceptional submillisecond timescale (>200 ms for
each system) using an explicit water model and thereby
characterize the structural ensembles of full length Ab42
and Ab40 monomers. In addition to the effects of peptide
length we report the effects of a pathogenic mutation, the
Italian mutation E22K, on Ab monomer structures. Our
data provide insights into how this pathogenic mutation
can alter the structural ensemble and, potentially, the oligo-
merization of Ab.
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MD simulations
Details of the MD simulations regarding system setup, simulation parame-
ters, simulation lengths, etc. can be found in the Supporting Material. For
each system, the total number of trajectories used for analysis was
~8000, the average simulation length of each trajectory was ~30 ns, and
the total accumulative simulation time was >200 ms. A number of conver-
gence checks were performed and the results can be found in the Supporting
Material.Markov state model analysis
MSM analysis was performed to identify representative conformations and
compute their equilibrium populations. For reviews and detailed description
on MSMs, please refer to (78–80). In brief, the MD trajectories were first
subsampled every 10 steps. The k-center clustering algorithm (81) with
the root mean-square deviation (RMSD) metric (RMSD of heavy atoms
common among all three systems in this study; however, heavy atoms in
the side chains that are torsionally degenerate, for example, CD1 and
CD2 in leucines, were excluded) was then performed on the subsampled
data to identify cluster centers and partition the configurations into different
states. The clustering procedure was performed until the newly identified
cluster center had a RMSD <5 A˚ from the previously identified represen-
tatives (convergence was reached). Using these cluster centers, state indices
were assigned to the full trajectories and transitions between states were
recorded at a lag time of 20 ns. With this transition matrix, the master equa-
tions were solved and equilibrium populations for each state (representative
conformation) deduced.RESULTS AND DISCUSSION
Characterizing the conformational ensemble for
intrinsically disordered full-length Ab peptides
Approximately 30,000 representative conformations were
identified in the Ab42 conformational ensemble by com-
paring structural similarity (see Methods). The Ab42 mono-
mer conformational ensemble displays great diversity and
no native state that is particularly populated relative to the
others could be identified. We performed principal com-
ponent analysis to analyze the RMSD of the peptide heavy
atoms (82,83). The free energy landscape of Ab42 is shown
as a function of the first and the second principal compo-
nents in Fig. 1. A single large cluster with no well-separated
basins is observed. In Fig. S4 in the Supporting Material the
free energy profile of Ab42 is projected on the peptide radius
of gyration and the peptide RMSD from the Ab fibril struc-
ture (backbone of residues 17–42) (11) and shows a rather
featureless contour as well. Each grid point also encom-
passes structures that show significant diversity. This is
consistent with the idea that Ab peptides are intrinsically
disordered (we specifically note that there has been a very
recent report on Ab42 structure using both NMR experi-
ments and MD simulations, in which Ab42 was found to
sample a highly heterogeneous structural ensemble (76)).
In Fig. 2, we show the conformations of the six most popu-
lated representative conformations in the Ab42 ensemble
(84). They have populations of only 0.17%, 0.16%, 0.13%,0.11%, 0.11%, and 0.10%, respectively. Thus, it is not appro-
priate to describe Ab42 using a number of representative
configurations. Instead, below we report the structural char-
acteristics of Ab42 by averaging over the full conformational
ensemble. Note that in Fig. 1 and Fig. S4, we show how the
results of principal component analysis and free energy land-
scape projection can depend on a number of independent
trajectories in the simulations. Although with all data sets
a single large cluster with no well-separated basins was
observed (top panels in Fig. 1 and Fig. S4), separated basins
could be (mis)identified when fewer trajectories were used
(bottom panels in Fig. 1 and Fig. S4).Ab42 forms short helix segments and hairpins
To investigate the local structural segments in the Ab42
ensemble, the secondary structures for each representative
conformation were assigned using the DSSP program
(85). To compute the ensemble-averaged secondary struc-
ture, the contribution from each representative conformation
was then weighted by its MSM population (see Methods).
In Fig. 3, we report the ensemble-averaged population of
each residue in Ab42 adopting one of the DSSP secondary
structures. The peptide conformations appear to be domi-
nated by the unstructured bend, turn, and loop/irregular,
which is rather consistent with the earlier NMR study of
Ab42 (35). However, we note that the region of residues
24–26 has a very high bend propensity. Bends are regions
with high curvature and a bend at residue i in the DSSP defi-
nition means the bond angle formed by the Ca atoms of resi-
dues i – 2, i, and i þ 2 is at least 70 (85). This high bend
propensity in the region of residues 24–26 is consistent
with previous experiment and simulation results on Ab frag-
ments (28,30,52,60,86).
We observed some preferential formation of a- and
310-helices, especially in the region of residues 10–20.
Through further length analysis of the helix segments as
described in Fig. S5, we found that in most conformations
only short a-helix segments involving four residues were
formed. This is noteworthy because a structural tool with
weak sensitivity to short a-helices such as circular
dichroism spectroscopy (87), may not detect the short helix
segments in the Ab42 monomer ensemble. Enhanced
310-helix structure was also observed near the N-terminus.
On average, there was a very low tendency to form p-helices
(<1%), isolated bridges (<3%), and extended b (<3%) for
all the residues in Ab42. Nonetheless, some b-hairpins were
indeed observed, mostly containing a glycine (G9, G25,
G29, G33, G37, G38) as part of their turns. Two b-hairpins
were particularly populated: a b-hairpin composed of resi-
dues I32 and G33, stabilized by antiparallel bridges between
A30$$$M35 and I31$$$L34 and a second b-hairpin
composed of residues G37 and G38, stabilized by antipar-
allel bridges M35$$$V40 and V36$$$V39, as can be seen
in the green E curve in the Fig. 3 inset.Biophysical Journal 102(2) 315–324





















































































































































FIGURE 1 Top: Free energy landscape (in kT)
of Ab42 as a function of the first and the second
principal components from the principal compo-
nent analysis using the root mean-square devia-
tions among conformations. Bottom: Dependence
of the principal component analysis results on
the number of independent trajectories during the
second-stage sampling. Upper left, upper right,
lower left, and lower right are the results from
10, 50, 100, and 500 independent trajectories,
respectively.
318 Lin et al.Ab42 decomposes into three tertiary regions
We analyzed the tertiary structure in the Ab42 ensemble by
calculating the ensemble-averaged contact map (plotted in
log scale in Fig. 4). Contacts between two residues are
defined by an 8 A˚ cutoff for their Ca-Ca distances (88).
Strong (i,iþ3) and (i,iþ4) contacts indicating helix forma-
tion are observed around residues 11–17, in accordance
with the secondary structure trend shown in Fig. 3. It alsoBiophysical Journal 102(2) 315–324appears the Ab42 monomer has three distinct tertiary regions
with substantial intraregion contacts: (I) an N-terminal re-
gion around residues 1–15, (II) a central region ranging
approximately from residues 16–23, and (III) a C-terminal
region expanding around residues 24–42. Notably, we ob-
served few contacts between regions II and III and even
fewer contacts between regions I and II.
Region I (~residues 1–15 with sequence DAEFR HDSGY
EVHHQ) has four residues with negatively charged side
FIGURE 2 Conformations of the six most popu-
lated representative conformations in the Ab42
ensemble. Secondary structure visualizations were
generated using VMD (84). The blue spheres in
the figure represent the N atoms in the N-terminal
amino groups. a-helices are shown in purple, 310-
helices in blue, extended b in yellow, isolated
b bridges in tan, turns in cyan, and loops/irregulars
in white. The secondary structure assignment was
generated using the STRIDE program implemented
in VMD.
Ab Monomer Ensembles 319chains, one residue with a positively charged side chain, and
three histidines; region II (~residues 16–23 with sequence
KLVFF AED) has a stretch of five hydrophobic residues
(often referred to as the central hydrophobic cluster) capped
by a residue with a positively charged side chain on one end
(K16), and by two residues with negatively charged side
chains on the other (E22 and D23); region III (~residues
24–42 with sequence VG SNKGA IIGLM VGGVV IA) is
mostly uncharged and hydrophobic, and is glycine-rich.
The lack of contacts between region I and region II may
be attributed to 1), the incompatibility between the charged
residues in region I and the hydrophobic side chains of resi-
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FIGURE 3 Ensemble-averaged %population of the secondary structures
based on the DSSP analysis for Ab42. The eight DSSP assignments are
a-helix (H), 310-helix (G), p-helix (I), isolated bridge (B), extended
b (E), bend (S), turn (T), or loop/irregular (~). Inset: Zoom in on the p-helix
(I), isolated bridge (B), and extended b (E) curves. The 1-s error bars were
calculated by dividing the total simulation data into 10 sets.four negatively charged residues in region I and the nega-
tively charged E22 and D23 in region II.Ab42 and Ab40 have crudely similar characteristics
but Ab40 has decreased b-propensity near
the C-terminus
To investigate the effects of peptide length on the Abmono-
mer structure, MD simulations were performed for Ab40. In
Fig. S6, we plot the distribution of radii of gyration (Rg) for
Ab42 and Ab40. Both Ab42 and Ab40 appear rather compact
and the similar Rg profiles suggest that the change in length
has small effects on the size distribution of the peptide. The
significance of the E22–K28 and D23–K28 salt bridges
have been discussed and debated in Ab fragment studies
(30,31,46,51,52,64,66,86). In Fig. S7, we plot the distribu-
tion of the E22–K28 and D23–K28 salt bridge distances.
The similar distance distributions suggest that the change
in length has small effects on E22–K28 and D23–K28
salt-bridge formation. In Fig. 5 (top panel), we compare
the residue-dependent tendency to adopt a a-helix con-
formation of Ab42 (black curve with sphere symbol) and
Ab40 (red curve with square symbol). Both Ab42 and Ab40
have similar residue dependence on their a-helix propensity.
Previous NMR studies have indicated b-hairpin forma-
tion near the C-terminus of Ab42 but not Ab40 (35). To
verify this finding in our simulations, in Fig. 5 we compare
the residue-dependent tendency to adopt a b-hairpin confor-
mation (bottom panel) of Ab42 (black curve with sphere
symbol) and Ab40 (red curve with square symbol). Although
the b-hairpin propensity appears low for both Ab42 and
Ab40 (with quite significant error bars), notably, the likeli-
hood to form a b-hairpin by 30AIIGLM35 and that by
35MVGGVV40 is significantly lower for Ab40. The simula-
tion result that peptide length does not strongly perturb the
a-helix propensity but reduces b-hairpin formation near the
C-terminus is consistent with the earlier observation from
NMR studies that suggested Ab42 and Ab40 have similarBiophysical Journal 102(2) 315–324
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FIGURE 5 Ensemble-averaged %population of a-helix (H) (top panel)
and extended b (E) (bottom panel) based on the DSSP analysis for Ab42
(black circle), Ab40 (red square), and Ab42-E22K (green diamond).
FIGURE 4 Ensemble-averaged contact map for Ab42 (in log scale). Two
residues are considered in contact when their Ca-Ca distance is <8 A˚ (88).
Note the (i,i), (i,i51), and (i,i52) contacts are not computed and result in
the purple diagonal shown in the figure.
320 Lin et al.global motions but that there is a tendency for residues
31–36 and 39–41 to populate b-strand conformations for
Ab42 and no such tendency for the C-terminal residues of
Ab40 (35,36). Although the absolute difference of extended
b-propensity near the C-terminus between the two peptides
in our simulations is a few percent (bottom panel of Fig. 5),
the b-hairpin formation near the C-terminus is ~threefold
higher in Ab42 relative to Ab40. This difference at the
molecular level may be critical for facilitating oligomeriza-
tion and could account for the faster aggregation of Ab42
relative to Ab40 (89).
We note a partially folded structure of Ab40 has been
reported recently using 2D NMR data (37). In this NMR
structure Ab40 forms a 310-helix from H13 to D23, and in
our simulations we indeed observed some preferential
formation of 310-helices (and a-helices) in the region of
residues 10–20 (for both Ab42 and Ab40). Nonetheless, in
our simulations no single native state could be identified
and our results are more compatible with the view that
full-length Ab peptides are intrinsically disordered with
highly heterogeneous structural ensembles (76).Comparison to previous Ab42/Ab40 simulation
results
MD simulation results of Ab42 and Ab40 using implicit
solvent models suggest that residues 30–36 have more
b-structure in Ab42 than in Ab40, and residues 39 and 40
have some b-structure in Ab42 but none in Ab40. Although
our findings in Fig. 5 are qualitatively consistent with these
results, the b-propensity from our explicit-solvent MD
simulations (<3% as seen in the bottom panel of Fig. 5) isBiophysical Journal 102(2) 315–324much lower than that reported from the implicit solvent
simulations (~30% in Fig. 6 of (44), ~6% in Fig. 3 of
(48), and ~15% in Fig. 5 of (49)).
The structural similarity of Ab42 and Ab40 has been pre-
dicted by implicit-solvent simulation studies (44,48,49) and
deduced from experiments (35,36). The similarity between
the two peptides, however, has not been observed in pre-
vious explicit-solvent simulations (73), possibly due to
insufficient sampling (74). In our explicit-solvent simula-
tions Ab42 and Ab40 have crudely similar characteristics.
Nonetheless, differences of b-propensity between the two
peptides were observed. It is important to fully characterize
Ab Monomer Ensembles 321the structural ensemble of intrinsically disordered peptides,
such as Ab, to accurately describe significant structural
differences.Italian E22K mutation increases helix propensity
in the region of residues 20–24
A number of mutations in APP have been related to familial
AD (6,7). The mutations usually occur at or near the b- and
g-secretase cleavage sites, besides which there are five path-
ogenic mutations in the region of A21, E22, and D23.
We performed simulations on the Italian mutant of Ab42,
Ab42-E22K, which aggregates at least twice as fast as
Ab42 (89), to investigate the effects of the E22K substitution
on the monomer conformation ensemble.
The E22K mutation has minimal effects on Ab42’s radius
of gyration and on salt-bridge formation between D23–K28
(see Fig. S6 and Fig. S7). Thus, in Fig. 5 we compare the
residue-dependent tendency to form an a-helix (top panel)
or a b-hairpin (bottom panel) in Ab42-E22K (green curve
with diamond symbol) to that in wild-type (WT) Ab42 (black
curve with sphere symbol). The difference contact map for
Ab42-E22K compared to the WT Ab42 is reported and dis-
cussed in the Supporting Material. As shown in Fig. 5,
Ab42-E22K showed significant a-helix propensity in the
region of residues 20–24, which is absent in Ab42, and
showed decreased helix propensity in the region of residues
30–35, compared to Ab42 (top panel of Fig. 5). This may be
attributed to 1), the electrostatic repulsion between E22 and
D23 in Ab42, which may destabilize any helices formed in
this region, is eliminated in Ab42-E22K, and/or 2), lysine
has a longer aliphatic chain than glutamate, which may
provide a more favorable hydrophobic interaction with (i-
4) V18 to stabilize a a-helix.
It is interesting to note that there have been studies report-
ing a a-helical kinetic intermediate during the oligomeriza-
tion of Ab (90). Such a a-helical intermediate may play a
general role in amyloid formation (91). Here, we found
that E22K induces helix formation in the region of residues
20–24 in Ab42-E22K, which is known to aggregate at least
twice as fast as the WT Ab42 (89). It should still be noted
that because this mutation replaces a negatively charged
glutamate by a positively charged lysine, it does change
the net charge of the Ab peptide from –3 to –1, which
may decrease Coulombic repulsion between monomers.
However, besides the change of the peptide net charge we
also note that the induced helix fragments in the region of
residues 20–24 in Ab42-E22K may increase helix-helix
interactions between monomers and could lead to alignment
of unstructured regions nearby the helices, thus promoting
oligomerization.
It is interesting to note that within the Ab sequence, A21,
E22, and D23 are most frequently mutated in familial AD
(7). Here, our simulation results on Ab42-E22K indicate
that the electrostatic repulsion between E22 and D23 mayprevent helix formation in the region of residues 20–24
and substitution of E22 by a positively charged lysine that
increases the helix propensity in this region. In WT Ab42,
the repulsion between these two negatively charged residues
(E22 and D23) and those near the N-terminus may prevent
substantial contacts between these two regions. The muta-
tion E22K is able to alter the structural ensemble of Ab
monomer by decreasing these electrostatic repulsions. We
note that in a pH dependence study of two Ab fragments
(Ab1–28 and Ab10–42), it was suggested that elimination of
charge from one of the E22 and D23 and replacement by
G, Q, or N would likely promote formation of a turn at resi-
dues 23–26 (46). In our Ab42-E22K simulation, the E22K
mutation not only eliminates the negative charge of E22
but also introduces a positive charge of K22, and this
promotes helix formation at residues 20–24 instead of turn
formation at residues 23–26. We also note that the study
here and the previous pH dependence study use different
force fields (AMBER ff99sb þ tip3p vs. CHARMM22 þ
GBSW) and although in our simulations the protonation
state of the peptide stays unchanged, constant pH MD was
implemented in the pH dependence study.CONCLUSIONS
Using distributed computing and Markov state model anal-
ysis, we report simulation results on a submillisecond time
scale for Ab42, Ab40, and Ab42-E22K. These simulations
enabled us to characterize the structural ensemble of Ab
monomer, the starting point for Ab aggregation, and investi-
gate how the ensemble structure is affected both by the
peptide length and by mutation. We observed many similar-
ities in the structural ensembles adopted by the Ab variants
studied here, but we also discovered some significant differ-
ences in specific regions of the monomers. Ab42, Ab40, and
Ab42-E22K monomers are largely not well structured, with
a slight tendency to form short a and 310-helix segments.
The helix-forming tendency is strongest in the region of resi-
dues 10–20 for Ab42 andAb40. Some formation of b-hairpins
was also observed, mostly employing a glycine in their turns.
b-hairpins between residues 30, 31 and residues 34, 35 (using
I32 and G33 as its turn) and between residues 35, 36 and resi-
dues 39, 40 (using G37 and G38 as its turn) are most popu-
lated in Ab42. The formation of both these b-hairpins is
substantially decreased in Ab40. The pathogenic Ab42-
E22K forms b-hairpins to a similar extent and at the same
locations as the WTAb42, but notably has increased a-helix
formation in the region of residues 20–24. These induced
helix fragments in the region of residues 20–24 may increase
helix-helix interactions between Ab42-E22K monomers and
could lead to alignment of unstructured regions nearby the
helices, thus promoting oligomerization. Future MD simula-
tions of other familial mutants with mutations at A21, E22,
and D23 will provide even more insights into the role of
this region in Ab structure.Biophysical Journal 102(2) 315–324
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